Quality of life and psychological impact of implantable cardioverter defibrillators: Focus on randomized controlled trial data

Cardiac Electrophysiology Review

Volumn 7, Issue 1, 2003, Pages 63-70

  McCready, Michael John ^a   Exner, Derek V ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CARDIOVERSION; CLINICAL OBSERVATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; DISTRESS SYNDROME; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; MEDICAL CARE; OUTCOMES RESEARCH; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SURVIVAL; WELLBEING;

ANTI-ARRHYTHMIA AGENTS; ATTITUDE TO HEALTH; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MYOCARDIAL ISCHEMIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0038208375     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023699225221     Document Type: Review

References (65)

1. Kolata G. Extending life, defibrillators can prolong misery. NY Times (Print) 2002:A1,18.
2. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102(7):748-754.
3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101(11):1297-1302.
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337(22):1576-1583.
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341(25):1882-1890.
6. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335(26):1933-1940.
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877-883.
8. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303(6):322-324.
9. Raj SR, Sheldon RS. The implantable cardioverter-defibrillator. Current indications and controversies. Minerva Cardioangiol 2002;50(4):273-290.
10. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC, Jr. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106(16):2145-2161.
11. Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S, Brodsky M, Powell J, Marchant C, Jennings C, Akiyama T. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation 2002;105(17):2049-2057.
12. O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M. Cost-effectiveness of the implantable cardioverter-defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS). Circulation 2001;103(10):1416-1421.
13. Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J 2002;144(3):440-448.
14. Sheldon R, O'Brien BJ, Blackhouse G, Goeree R, Mitchell B, Klein G, Roberts RS, Gent M, Connolly SJ. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian implantable defibrillator study. Circulation 2001;104(14):1622-1626.
15. Hsu J, Uratsu C, Truman A, Quesenberry C, McDonald KM, Hlatky MA, Selby J. Life after a ventricular arrhythmia. Am Heart J 2002;144(3):404-412.
16. Pycha C, Calabrese JR, Gulledge AD, Maloney JD. Patient and spouse acceptance and adaptation to implantable cardioverter defibrillators. Cleve Clin J Med 1990;57(5):441-444.
17. Pycha C, Gulledge AD, Hutzler J, Kadri N, Maloney J. Psychological responses to the implantable defibrillator: Preliminary observations. Psychosomatics 1986;27(12): 841-845.
18. Morris PL, Badger J, Chmielewski C, Berger E, Goldberg RJ. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics 1991;32(1):58-64.
19. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. Pacing Clin Electrophysiol 1999;22(9):1305-1313.
20. Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol 2000;23(6):934-938.
21. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, Curtis AB, Conti JB. Assessing the psychosocial impact of the ICD: A national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000;23(6):939-945.
22. Herbst JH, Goodman M, Feldstein S, Reilly JM. Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol 1999;22(6 Pt 1):915-926.
23. Herrmann C, von zur Muhen F, Schaumann A, Buss U, Kemper S, Wantzen C, Gonska BD. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997;20(1 Pt 1):95-103.
24. May CD, Smith PR, Murdock CJ, Davis MJ. The impact of the implantable cardioverter defibrillator on quality-of-life. Pacing Clin Electrophysiol 1995;18(7):1411-1418.
25. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105(5):589-594.
26. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144(2):282-289.
27. Schaumann A, von zur Muhlen F, Herse B, Gonska BD, Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients. Circulation 1998;97(1):66-74.
28. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104(7):796-801.
29. Flemme I, Bolse K, Ivarsson A, Jinhage BM, Sandstedt B, Edvardsson N, Fridlund B. Life situation of patients with an implantable cardioverter defibrillator: A descriptive longitudinal study. J Clin Nurs 2001;10(4):563-572.
30. Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg S. Psychosocial outcome after ICD implantation: A current perspective. Pacing Clin Electrophysiol 1998;21(6):1207-1215.
31. Kalbfleisch KR, Lehmann MH, Steinman RT, Jackson K, Axtell K, Schuger CD, Tchou PJ. Reemployment following implantation of the automatic cardioverter defibrillator. Am J Cardiol 1989;64(3):199-202.
32. Jung W, Anderson M, Camm AJ, Jordaens L, Petch MC, Rosenqvist M, Santini M, Luderitz B. Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on 'ICD and Driving' of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J 1997;18(8):1210-1219.
33. Finch NJ, Sneed NV, Leman RB, Watson J. Driving with an internal defibrillator: Legal, ethical, and quality-of-life issues. J Cardiovasc Nurs 1997;11(2):58-67.
34. Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med 2001;345(6):391-397.
35. Hamner M, Hunt N, Gee J, Garrell R, Monroe R. PTSD and automatic implantable cardioverter defibrillators. Psychosomatics 1999;40(1):82-85.
36. Sears SF, Jr., Conti JB, Curtis AB, Saia TL, Foote R, Wen F. Affective distress and implantable cardioverter defibrillators: Cases for psychological and behavioral interventions. Pacing Clin Electrophysiol 1999;22(12):1831-1834.
37. Neel M. Posttraumatic stress symptomatology in patients with automatic implantable cardioverter defibrillators: Nature and intervention. Int J Emerg Ment Health 2000;2(4):259-263.
38. Carroll DL, Hamilton GA, McGovern BA. Changes in health status and quality of life and the impact of uncertainty in patients who survive life-threatening arrhythmias. Heart Lung 1999;28(4):251-260.
39. Irvine J, Newman D. Quality of life issues in the management of patients with ventricular arrhythmias. Can J Cardiol 2000;16(Suppl C):41C-44C.
40. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91(4):999-1005.
41. Sears SF, Jr., Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review. Clin Cardiol 1999;22(7):481-489.
42. Reich P. Psychological predisposition to life-threatening arrhythmias. Annu Rev Med 1985;36:397-405.
43. Reich P, DeSilva RA, Lown B, Murawski BJ. Acute psychological disturbances preceding life-threatening ventricular arrhythmias. Jama 1981;246(3):233-235.
44. Lown B, DeSilva RA, Reich P, Murawski BJ. Psychophysiologic factors in sudden cardiac death. Am J Psychiatry 1980;137(11):1325-1335.
45. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999;9(4):163-168.
46. Kuijpers PM, Honig A, Wellens HJ. Effect of treatment of panic disorder in patients with frequent ICD discharges: A pilot study. Gen Hosp Psychiatry 2002;24(3):181-184.
47. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Jr., Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, MeLvor M. Sertraline treatment of major depression in patients with acute MI or unstable angina. Jama 2002;288(6):701-709.
48. Katon W, Schulberg H. Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992;14(4):237-247.
49. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51(1):8-19.
50. Gotay CC. Trial-related quality of life: Using quality-of-life assessment to distinguish among cancer therapies. J Natl Cancer Inst Monogr 1996;20:1-6.
51. World Health Organization. The First Ten Years of the World Health Organization. Geneva: World Health Organization, 1958.
52. Jenkins L. Quality of Life in Survivors of Sudden Cardiac Death Entering Treatment. Futura Publishing Company, 1997:289-305.
53. Steinberg J, Vloka M, Qing Y, Schron E, Dorian P, Powell J. Relationship of baseline quality of life scores to long-term survival in the antiarrhythmics versus implantable defibrillators (AVID) trial (abstract). Circulation 1999;100:1925.
54. Stevenson LW. Inotropic therapy for heart failure. N Engl J Med 1998;339(25):1848-1850.
55. Vlay SC. The automatic internal cardioverter-defibrillator: Comprehensive clinical follow-up, economic and social impact - the Stony Brook experience. Am Heart J 1986;112(1):189-194.
56. Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. Pacing Clin Electrophysiol 1989;12(2):366-373.
57. Dunbar SB, Warner CD, Purcell JA. Internal cardioverter defibrillator device discharge: Experiences of patients and family members. Heart Lung 1993;22(6):494-501.
58. Arteaga WJ, Windle JR. The quality of life of patients with life-threatening arrhythmias. Arch Intern Med 1995;155(19):2086-2091.
59. Duru F, Buchi S, Klaghofer R, Mattmann H, Sensky T, Buddeberg C, Candinas R. How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart 2001; 85(4):375-379.
60. Bigger JT, Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997;337(22):1569-1575.
61. Ware JE, Jr. Validity: Norm-based interpretation. In: SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1997:10-38.
62. Dougherty CM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung 1995;24(4):281-291.
63. Stewart AL, Ware JE, Jr., Sherbourne CD. Psychological distress/well-being and cognitive functioning measures. In: Stewart AL, Ware JE, Jr., eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992:102-142.
64. Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients' long-term adjustment to the ICD: A prospective study. Pacing Clin Electrophysiol 2000;23(4 Pt 1):450-456.
65. Exner DV, Klein GJ, Prystowsky EN. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?). Circulation 2001;104(13):1564-1570.